Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Titralac 420mg tablets
0905022H0BBAAAA
|
Titralac | Calcium carbonate | Nutrition and Blood | No data available |
|
Tivicay 10mg tablets
0503010AHBBABAB
|
Tivicay | Dolutegravir | Infections | No data available |
|
Tivicay 25mg tablets
0503010AHBBACAC
|
Tivicay | Dolutegravir | Infections | No data available |
|
Tivicay 50mg tablets
0503010AHBBAAAA
|
Tivicay | Dolutegravir | Infections | No data available |
|
Tivozanib 1340microgram capsules
0801050CVAAAAAA
|
Tivozanib | Tivozanib | Malignant Disease and Immunosuppression | No data available |
|
Tivozanib 890microgram capsules
0801050CVAAABAB
|
Tivozanib | Tivozanib | Malignant Disease and Immunosuppression | No data available |
|
Tixycolds Cold and Allergy nasal drops
1202020P0BIAAAA
|
Tixycolds (Nasal) | Xylometazoline hydrochloride | Ear, Nose and Oropharynx | No data available |
|
Tixycolds Cold and Hayfever Inhalant capsules
0308000M0BEAAA0
|
Tixycolds (Inhalation) | Menthol | Respiratory System | No data available |
|
Tixycolds syrup sugar free
0304010N0BRAAAT
|
Tixycolds | Diphenhydramine hydrochloride | Respiratory System | No data available |
|
Tixylix Chesty Cough 50mg/5ml oral solution
0309020G0BGABAN
|
Tixylix (Guaifenesin) | Guaifenesin | Respiratory System | No data available |
|
Tixylix Children's Dry & Tickly Cough 15% syrup
0309020H0BHAFAH
|
Tixylix (Glycerol) | Glycerol | Respiratory System | No data available |
|
Tixylix Cough & Cold oral solution
030902000BEDEA0
|
Proprietary compound preparation BNF 0309020 | Other expectorantand demulcent cough preparations | Respiratory System | No data available |
|
Tixylix Dry Cough 4mg/5ml oral solution
0309010X0BPAAAA
|
Tixylix Daytime | Pholcodine | Respiratory System | No data available |
|
Tixylix Honey, Lemon & Glycerol oral solution
0309020H0BHACAE
|
Tixylix (Glycerol) | Glycerol | Respiratory System | No data available |
|
Tixylix Night Cough oral solution
030902030BEACAH
|
Tixylix (Pholcodine/promethazine) | Pholcodine | Respiratory System | No data available |
|
Tizanidine 4mg/5ml oral liquid
1002020T0AAAEAE
|
Tizanidine hydrochloride | Tizanidine hydrochloride | Musculoskeletal and Joint Diseases | No data available |
|
Tizanidine 5mg/5ml oral suspension
1002020T0AAAKAK
|
Tizanidine hydrochloride | Tizanidine hydrochloride | Musculoskeletal and Joint Diseases | No data available |
|
Tizanidine 6mg/5ml oral suspension
1002020T0AAALAL
|
Tizanidine hydrochloride | Tizanidine hydrochloride | Musculoskeletal and Joint Diseases | No data available |
|
Tizanidine 8mg/5ml oral liquid
1002020T0AAAHAH
|
Tizanidine hydrochloride | Tizanidine hydrochloride | Musculoskeletal and Joint Diseases | No data available |
|
Tobramycin 170mg/1.7ml nebuliser liquid ampoules
0501040U0AAANAN
|
Tobramycin (Systemic) | Tobramycin | Infections | No data available |
|
Tobramycin 20mg/2ml solution for injection vials
0501040U0AAAAAA
|
Tobramycin (Systemic) | Tobramycin | Infections | No data available |
|
Tobramycin 20mg/5ml oral solution
0501040U0AAAMAM
|
Tobramycin (Systemic) | Tobramycin | Infections | No data available |
|
Tobramycin 240mg/6ml solution for injection vials
0501040U0AAAIAI
|
Tobramycin (Systemic) | Tobramycin | Infections | No data available |
|
Tobramycin 3mg/ml eye drops
1103010X0AAAAAA
|
Tobramycin (Eye) | Tobramycin | Eye | No data available |
|
Tobramycin 40mg/1ml solution for injection ampoules
0501040U0AAAEAE
|
Tobramycin (Systemic) | Tobramycin | Infections | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.